Efficacy of GM6001 as an adjuvant to ceftriaxone In a neonatal rat model of Streptococcus pneumoniae meningitis

• Autorzy: Liu X. , Han Q.
• Języki publikacji: EN

Abstrakty

EN

Evidence has demonstrated that matrix metalloproteinases (MMPs) contribute to the pathophysiology of bacterial meningitis; therefore, MMP inhibitors may be a neuroprotective treatment for brain injury caused by meningitis because of their anti¬inflammatory effects. The objective of this study was to evaluate the effect of the MMP inhibitor GM6001 in a rat model of S. pneumoniae meningitis. For these experiments, 7-day-old Sprague-Dawley rats were randomly divided into an uninfected group, meningitis group, antibiotic group and GM6001+antibiotic group. Uninfected animals were sham infected with sterile saline. Rats in the other three groups were inoculated with S. pneumoniae and left untreated, treated with ceftriaxone, or treated with ceftriaxone combined with GM6001. Rats in the meningitis group were severely ill, and MMP-9 was significantly up-regulated. The change in brain water content was consistent with the MMP-9 level. A significant loss of neurons and impaired learning function were observed in the meningitis group. Treatment with the antibiotic and GM6001 significantly down-regulated the level of MMP-9, decreased the brain water content, attenuated neuronal injury and improved learning. Conclusions: GM6001 protected the brain from damage caused by S. pneumoniae, and this effect may occur via down- regulating MMP-9 and decreasing brain water content.

• Wydawca: -
• Czasopismo: Acta Neurobiologiae Experimentalis
• Rocznik: 2014
• Tom: 74
• Numer: 4
• Opis fizyczny: p.489-496,fig.,ref.

Twórcy

autor

Liu X.

• Department of Pediatrics, Qilu Hospital, Shandong University, and Brain Science Research Institute, Shandong University, Jinan, P.R. China

autor

Han Q.

• Department of Respiratory Medicine, Provincial Hospital Affiliated to Shandong University, Jinan, P.R. China

Bibliografia

• Barber PA, Rushforth D, Agrawal S, Tuor UI. Infrared opti¬cal imaging of matrix metalloproteinases (MMPs) up regulation following ischemia reperfusion is ameliorated by hypothermia. BMC Neurosci. 2012; 13:76.
• Bashir EI H, Laundy M, Booy R.Diagnosis and treatment of bacterial meningitis. Arch Dis Child. 2003; 88: 615-20.
• Candelario-Jalil E, Taheri S, Yang Y, Sood R, Grossetete M, Estrada EY, Fiebich BL, Rosenberg GA (2007) Cyclooxygenase inhibition limits blood-brain barrier dis¬ruption following intracerebral injection of tumor necro¬sis factor-alpha in the rat. J Pharmacol Exp Ther 323: 488-498.
• Chen KM, Lee HH, Chou HL, Liu JY, Tsai BC, Lai SC (2005) Upregulation of MMP-9/TIMP-1 enzymatic sys¬tem in eosinophilic meningitis caused by Angiostrongylus cantonensis. Int J Exp Pathol 86: 81-89.
• Deb S, Gottschall PE (1996) Increased production of matrix metalloproteinases in enriched astrocyte and mixed hippocampal cultures treated with beta-amyloid peptides. J Neurochem 66: 1641-1647.
• Dencoff JE, Rosenberg GA, Harry GJ (1997) Trimethyltin induces gelatinase B and urokinase in rat brain. Neurosci Lett 228: 147-150.
• Fernandes KS, Brum DG, Palei AC, Sandrim VC, Guerreiro CT, Tanus-Santos JE, Barreira AA (2012)
• Functional MMP-9 polymorphisms modulate plas¬ma MMP-9 levels in multiple sclerosis patients. J Neuroimmunol 249: 56-59.
• Gijbels K, Galardy RE, Steinman L (1994) Reversal of experimental autoimmune encephalomyelitis with a hydroxamate inhibitor of matrix metalloproteases. J Clin Invest 94: 2177-2182.
• Gottschall PE, Deb S (1996) Regulation of matrix metallo- proteinase expressions in astrocytes, microglia and neu¬rons. Neuroimmunomodulation 3: 69-75.
• Grandgirard D, Steiner O, Täuber MG, Leib SL (2007) An infant mouse model of brain damage in pneumococcal meningitis. Acta Neuropathol 114: 609-617.
• Hoffmann O, Mahrhofer C, Rueter N, Freyer D, Bert B, Fink H, Weber JR (2007) Pneumococcal cell wall-induced meningitis impairs adult hippocampal neurogenesis. Infect Immun 75: 4289-4297.
• Hsieh HL, Lin CC, Shih RH, Hsiao LD, Yang CM (2012) NADPH oxidase-mediated redox signal contributes to lipoteichoic acid-induced MMP-9 upregulation in brain astrocytes. J Neuroinflammation 6: 110.
• Kim CS, Jung S, Jung TY, Jang WY, Sun HS, Ryu HH (2011) Characterization of invading glioma cells using molecular analysis of leading-edge tissue. J Korean Neurosurg Soc 50: 157-165.
• Lai SC, Jiang ST, Chen KM, Hsu JD, Shyu LY, Lee HH (2005) Efficacy of albendazole-GM6001 co-thera¬py against Angiostrongylus cantonensis-induced menin¬gitis in BALB/c mice. Acta Trop 93: 267-273.
• Leib SL, Clements JM, Lindberg RL (2001) Inhibition of matrix metalloproteinases and tumour necrosis factor alpha converting enzyme as adjuvant therapy in pneumo- coccal meningitis. Brain 124: 1734-1742.
• Leib SL, Leppert D, Clements J, Tauber MG (2000) Matrix metalloproteinases contribute to brain damage in experi¬mental pneumococcal meningitis. Infect Immun 68: 615-620.
• Liu X, Han Q, Sun R, Li Z (2008) Dexamethasone regula¬tion of matrix metalloproteinase expression in experi¬mental pneumococcal meningitis. Brain Res 1207: 237¬243.
• Meli DN, Loeffler JM, Baumann P, Neumann U, Buhl T, Leppert D, Leib SL (2004) In pneumococcal meningitis a novel water-soluble inhibitor of matrix metalloproteinas- es and TNF-alpha converting enzyme attenuates seizures and injury of the cerebral cortex. J. Neuroimmunol 151: 6-11.
• Meli DN, Christen S, Leib SL, T€auber MG (2002) Current concepts in the pathogenesis of meningitis caused by Streptococcus pneumoniae. Curr Opin Infect Dis 15: 253-257.
• Mizoguchi H, Yamada K, Nabeshima T (2011) Matrix met- alloproteinases contribute to neuronal dysfunction in animal models of drug dependence, Alzheimer's disease, and epilepsy. Biochem Res Int, ID 681385 [http://dx.doi. org/10.1155/2011/681385].
• 0stergaard C (2007) Streptococcus pneumoniae meningitis. Dan Med Bull 54: 189-209.
• Pagenstecher A, Stalder AK, Kincaid CL, Shapiro SD, Campbell IL (1998) Differential expression of matrix met- alloproteinase and tissue inhibitor of matrix metalloprotei- nase genes in the mouse central nervous system in normal and inflammatory states. Am J Pathol 152: 729-741.
• Rosenberg GA, Estrada EY, Mobashery S (2007) Effect of synthetic matrix metalloproteinase inhibitors on lipopoly- saccharide-induced blood-brain barrier opening in rodents: Differences in response based on strains and solvents. Brain Res 1133: 186-192.
• Scheld WM, Koedel U, Nathan B, Pfister HW (2002) Pathophysiology of bacterial meningitis: Mechanism(s) of neuronal injury. J Infect Dis 186: S225-S233.
• Schubert-Unkmeir A, Konrad C, Slanina H, Czapek F, Hebling S, Frosch M (2010) Neisseria meningitidis induces brain microvascular endothelial cell detachment from the matrix and cleavage of occludin: a role for MMP-8. PLoS Pathog 6: e1000874.
• Sulik A, Chyczewski L (2008) Immunohistochemical analy¬sis of MMP-9, MMP-2 and TIMP-1, TIMP-2 expression in the central nervous system following infection with viral and bacterial meningitis. Folia Histochem Cytobiol 46: 437-442.
• Thai SC, Sporer S, Schmid-Elsaesser R, Plesnila N, Zausinger S (2009) Inhibition of bradykinin B2 receptors before, not after onset of experimental subarachnoid hemorrhage prevents brain edema formation and improves functional outcome. Crit Care Med 37: 2228-2234.
• Vorhees CV, Williams MT (2006) Morris water maze: pro¬cedures for assessing spatial and related forms of learning and memory. Nat Protoc 1: 848-858.
• Wang HH, Hsieh HL, Yang CM (2010) Calmodulin kinase II-dependent transactivation of PDGF receptors mediates astrocytic MMP-9 expression and cell motility induced by lipoteichoic acid. J Neuroinflammation 7: 84.
• Wang P, Ba ZF, Galardy RE, Chaudry IH (1996) Administration of a matrix metalloproteinase inhibitor after hemorrhage improves cardiovascular and hepato- cellular function. Shock 6: 377-382.